Home » Stocks » PPD, Inc.

PPD, Inc. (PPD)

Stock Price: $26.88 USD 0.26 (0.98%)
Updated Jul 2, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 9.37B
Revenue (ttm) 4.14B
Net Income (ttm) n/a
Shares Out 348.58M
EPS (ttm) 0.21
PE Ratio 128.00
Forward PE 27.93
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Jul 2, 2020
Last Price $26.88
Previous Close $26.62
Change ($) 0.26
Change (%) 0.98%
Day's Open 26.97
Day's Range 26.59 - 27.56
Day's Volume 414,337
52-Week Range 10.61 - 33.23

More Stats

Market Cap 9.37B
Enterprise Value 13.19B
Earnings Date (est) Aug 6, 2020
Ex-Dividend Date n/a
Shares Outstanding 348.58M
Float 136.08M
EPS (basic) n/a
EPS (diluted) 0.21
FCF / Share n/a
Dividend n/a
Dividend Yield n/a
Earnings Yield 0.78%
FCF Yield n/a
Payout Ratio n/a
Shares Short 2.88M
Short Ratio 3.56
Short % of Float 2.37%
Beta n/a
PE Ratio 128.00
Forward PE 27.93
P/FCF Ratio n/a
PS Ratio 2.26
PB Ratio n/a
Revenue 4.14B
Operating Income n/a
Net Income n/a
Free Cash Flow n/a
Net Cash -3.82B
Net Cash / Share -10.97
Gross Margin 61.52%
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA 4.82%
ROE n/a
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (15)

Buy 14
Overweight 1
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(17.04% upside)
Current: 26.88
Target: 31.46
*Average 12-month price target from 14 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth7.52%24.92%12%-
Gross Profit1,6221,4741,4641,293
Operating Income417373218286
Net Income47.82104296183
Shares Outstanding279279291312
Earnings Per Share0.190.340.680.58
EPS Growth-44.12%-50%17.24%-
Operating Cash Flow433423359408
Capital Expenditures-126-116-105-90.22
Free Cash Flow307307254318
Cash & Equivalents3455534190.00
Total Debt5,8444,7964,822-
Net Cash / Debt-5,498-4,243-4,4030.00
Book Value-2,698-1,522-1,492-
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name PPD, Inc.
Country United States
Employees 23,000
CEO David S. Simmons

Stock Information

Ticker Symbol PPD
Stock Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Unique Identifier NASDAQ: PPD


PPD, Inc. provides drug development services to the biopharmaceutical industry worldwide. The company operates through Clinical Development Services and Laboratory Services segments. It offers clinical development services, including product development and consulting, early development, Phases II-IV clinical trial management, accelerated enrollment, peri- and post-approval, and medical communications services. The company also provides laboratory services comprising bioanalytical, biomarker, vaccine science, good manufacturing practice, and central laboratory services. It serves pharmaceutical, biotechnology, medical device, and government organizations, as well as other industry participants. The company was founded in 1985 and is headquartered in Wilmington, North Carolina.